CoreCivic (CXW) Q4 2025 earnings review
ICE Demand Supercharges Growth, Guidance Signals Acceleration
CoreCivic delivered a transformative quarter, with Q4 revenue surging 26% YoY to $604M, driven by a doubling of ICE revenue as idle facilities came online. While net income rose 38%, profit margins were temporarily dampened by $3.6M in start-up costs for activating the California City and Diamondback facilities. Management's 2026 guidance is highly bullish, forecasting ~20% EBITDA growth and ~40% EPS expansion as these facilities stabilize, confirming the thesis that the 'One Big Beautiful Bill Act' funding is converting into tangible financial velocity.
🐂 Bull Case
Revenue from ICE, the company's largest partner, exploded to $244.7M in Q4 (+103% YoY) as operations resumed at the 2,400-bed Dilley facility and ramped at others. The federal demand thesis is fully playing out.
Guidance for 2026 projects Adjusted EBITDA of $437M-$445M, implying ~20% growth over 2025. EPS is guided to jump from $1.08 to ~$1.54, driven by the stabilization of recently activated facilities.
🐻 Bear Case
Operating margins in the Safety/Community segments compressed to 22.2% from 23.6% a year ago. Activating large facilities creates a temporary mismatch where staffing costs precede full revenue recognition, dragging near-term profitability.
The 1,033-bed Midwest Regional Reception Center remains in legal limbo due to a lawsuit from the City of Leavenworth. This delays potential ~$60M in annual revenue and leaves capital stranded in an idle asset.
⚖️ Verdict: 🟢🟢
Strong Buy. The company is in the midst of a historic growth inflection. The 26% revenue growth is just the start, with 2026 guidance confirming that the heavy lifting of facility reactivations will translate into massive earnings leverage. Aggressive buybacks (5.3M shares in Q4) signal management's high confidence.
Key Themes
Surging Federal Demand (ICE)
The demand environment has shifted dramatically. ICE revenue more than doubled YoY ($244.7M vs $120.3M). This is not just one contract; it is a broad-based surge involving the reactivation of the Dilley facility, the acquisition of Farmville, and new utilization at West Tennessee and California City.
Operational Margin Compression
Rapid growth comes with a cost. Facility operating margins dropped 140bps YoY to 22.2%. The company incurred $3.6M in specific operating losses at the California City and Diamondback facilities during Q4 as they hired staff before full occupancy. While 2026 guidance implies recovery, execution risk remains high as multiple facilities ramp simultaneously.
Aggressive Capital Return
Management is aggressively buying the dip/growth story. CoreCivic repurchased 5.3 million shares in Q4 alone for $97.3M, and 11.2 million shares for the full year ($218.4M). They still have $300.5M remaining on the authorization. This reduces the share count significantly (diluted shares fell from 111.4M to 104.0M YoY), amplifying EPS growth.
Midwest Regional Legal Blockade
The 1,033-bed Midwest Regional Reception Center is a drag. Despite having a contract, the intake process is halted by a Special Use Permit dispute with the City of Leavenworth. Management has filed for the permit after failing in federal court, but the timing is indefinite. This strands capital and delays ~$60M in potential high-margin revenue.
State Segment Stability
While federal growth steals the headlines, State revenue grew 5.0% YoY. Growth was highlighted in Georgia, Montana, and Colorado. This segment provides a stable baseload of revenue (approx. $800M annual run rate) that diversifies risk away from federal policy volatility.
Rising Corporate Expenses
General and Administrative expenses rose 9.5% YoY to $44.4M in Q4. Interest expense also ticked up to $17.8M (vs $15.7M) despite lower rates, likely due to higher utilization of the credit facility to fund activations and buybacks. Monitoring these expense lines is crucial as they eat into the operating leverage from revenue growth.
Other KPIs
Accelerating. Up 25% YoY from $74.2M in 24Q4. Growth was driven by the Dilley resumption and Farmville acquisition, partially offset by start-up losses. This is the highest quarterly EBITDA of FY25, setting a strong exit rate for 2026.
Accelerating. Up 33% YoY. The growth outpaced EBITDA growth due to the 6.6% reduction in share count from aggressive buybacks. This metric is the best proxy for cash generation available to shareholders.
Stable but elevated. Ended the quarter at 2.8x, slightly above the typical 2.25x-2.75x target range often cited. This reflects the dual capital demands of facility activation CapEx ($35-40M planned for activations) and aggressive share repurchases.
Guidance
Accelerating. The midpoint ($441M) implies a 20.6% increase over FY25's $365.6M. This confirms that the margin compression seen in 25Q4 is temporary and that the new contracts will reach stabilized profitability in 2026.
Accelerating. Midpoint of $1.54 represents a 43% jump from FY25's $1.08. The outsized growth relative to EBITDA reflects the compounding benefit of share buybacks and operating leverage.
Accelerating. Midpoint of $2.59 implies 26% growth vs FY25's $2.05. This strong cash flow outlook supports continued share repurchases or debt reduction.
Key Questions
Midwest Litigation Timeline
With the federal lawsuit unsuccessful and the SUP application just filed in December 2025, is there a realistic path to activating the Midwest Regional facility in the first half of 2026, or should investors treat this as a 2027 opportunity?
Start-up Cost Cadence
Q4 saw $3.6M in start-up losses. How much of this drag persists into Q1 and Q2 2026 before the California City and Diamondback facilities flip to being accretive?
Leverage vs. Buybacks
Leverage sits at 2.8x, slightly above the historical target. Given the $300M remaining buyback authorization, will you prioritize deleveraging in H1 2026, or continue the aggressive repurchase pace given the strong EBITDA outlook?